ABSTRACT: Consumption of CLA by lactating women affects the composition of their milk, but the pattern of the different CLA isomers is still unknown. We determined the effects of short maternal supplementation with CLA-rich Alpine butter on the occurrence of FA and CLA isomers in human milk. In an open randomized controlled study with a two-period cross-over design, milk FA and CLA isomer concentrations were measured on postpartum days ≥20 in two parallel groups of lactating women before, during, and after consumption of defined quantities of Alpine butter or margarine with comparable fat content (10 d of butter followed by 10 d of margarine for one group, and vice versa in the other). In the 16 women who completed the study (8/group), Alpine butter supplementation increased the C 16 and C 18 FA, the sum of saturated FA, the 18:1 trans FA, and the trans FA with CLA. The CLA isomer 18:2 c9,t11 increased by 49.7%. Significant increases were also found for the isomers t9,t11, t7,c9, t11,c13, and t8,c10 18:2. The remaining nine of the total 14 detectable isomers showed no changes, and concentrations were <5 mg/100 g fat. A breastfeeding mother can therefore modulate the FA/CLA supply of her child by consuming Alpine butter. Further studies will show whether human milk containing this FA and CLA isomer pattern acts as a functional food for newborns.
Human milk (from German women) contains more longchain FA, with chain lengths of C 20 to C 24 including several double bonds, than bovine milk fat. It contains a high proportion of palmitic acid (16:0, 25.3%) and the isomeric groups of 18:1 and 18:2, their main components being oleic acid (c9, 29.0%) and linoleic acid (c9,c12, 9.5%) (8) .
The major CLA isomer is c9,t11-octadecadienoic acid (c9,t11 18:2) (1), also called rumenic acid (2) . Although linoleic acid is isom-erized by the enzymatic conversion of the c12 to the t11 bond by the anaerobe Butyrivibrio fibrisolvens in the rumen (3) , an estimated 64% of dairy milk fat CLA is of endogenous origin (4) . Total CLA and isomer concentrations in dairy milk fat depend on feeding (i.e., pasture, oilseeds), the effects of altitude and season, as well as the age and breed of the cow (5-7). Total CLA and isomer concentrations in human milk depend on maternal diet, stage of lactation, and de novo synthesis (8) (9) (10) (11) (12) . As humans do not synthesize PUFA, concentrations depend exclusively on dietary fat intake (13) . A study reporting CLA concentrations (c9,t11 isomer) of 5.8 mg/g fat in milk from mothers on conventional diets vs. 11.2 mg/g fat in Hare Krishna mothers hypothesized that the difference was due to the large amounts of butter, ghee, and cheese consumed by the latter (9) . Chronic dietary c9,t11 18:2 intake is thought to increase milk 18:2 c9,t11 concentrations (10) . The proportions of partially hydrogenated oils and ruminant fats in the diet also determine trans 18:1 isomeric distribution (8), whereas maternal diet, i.e.. consumption of different products or amounts of milk and meat, has been shown to correlate with differences in the CLA content of human milk (11) .
Several effects of a high-CLA diet in animals and humans have been described. However, for the effect of most interest to us, that on neonatal development, only animal data are available: in rats, increased milk CLA concentrations in dams on a high-CLA diet are associated with enhanced pup weight gain (14) . Recent studies have also shown that individual isomers have different effects.
The aim of the present investigation as an essential preliminary to an efficacy study was to quantify CLA isomers and FA concentrations in human milk from mothers consuming defined quantities of CLA-rich Alpine butter.
www.unilever.com) containing 24 g fat and 16 g water. From D11 through D20 (period 2), the diet was supplemented with 30 g/d (3 packages of 10 g per 24 h) Alpine butter (AB) containing 25.7 g fat, 4.3 g water, and an average of 2.09 g CLA/100 g milk fat (equivalent to approximately 0.5 g CLA/d). The difference between the daily amount of M (30 g) and AB (40 g), respectively, should result in an equal daily fat intake from the study products. Group 2 women followed the same dietary schedule in reverse order (period 1: AB; period 2: M).
The Alpine butter originated from Alp Mutten (Graubün-den, Switzerland, 2100 m altitude) and consisted of a blend of five 2-kg portions that was produced between July 1 and 25, 2003, and stored at −20°C until use. The 10-g portions of this blend contained 8.6 g fat, 1.4 g water, and 180.0 mg total CLA (corresponding to 2.09 g total CLA/100 g milk fat). The predominant CLA isomers were c9,t11, t11,c13, t7,c9, and t8,c10 18:2. The FA and CLA composition of the two supplements is shown in Table 1 .
The women had to record the real daily intake of study products (weight). No additional Alpine milk or ruminant meat products were allowed during the study.
Dietary diary. The subjects documented potential additional sources of CLA by recording every day the estimated intake (volume or weight) of milk and dairy products (yogurt, sour cream, cream, cheese, etc.) and meat (type). The amount of a consumed product was given in the database of the EBIS program (15) , which transforms the consumed volume or weight of a product in consumed grams fat by considering the product's specific percent fat. From the daily fat intake, the daily CLA intake (milligrams) was calculated using the values of Fritsche and Steinhart (16, 17) for CLA amounts (grams CLA per gram fat) in different foods (German and others); for chicken or turkey the CLA values of Chin et al. (1) were used.
Milk sampling. On D1, D5, D10, D15, and D20, the subjects took milk samples at home according to a standardized procedure assisted by the principal investigator (IB): between 8:00 and 11:00 A.M. and 1-3 h after a continental breakfast, the breast that was not actually used for infant feeding at the last feed was emptied completely using an electric pump (Lactina TM Electric plus; Medela AG, Baar, Switzerland) and the volume measured; 2 × 10-mL aliquots were transferred to plastic tubes, cooled at +4°C (cold box), and stored at −20°C until analysis. The remainder was fed to the baby.
Lipid extraction and analysis of FA. (i) Lipid extraction. Milk fat was obtained gravimetrically using the Roese-Gottlieb method, i.e., the fat globule membranes were disrupted with ammonia and ethanol, the fat was extracted with diethyl ether and petroleum ether, and the pure fat was stored at −20°C until analysis (18) .
(ii) FA. The milk fat was dissolved in hexane, and the glycerides were transesterified to the corresponding FAME using a solution of potassium hydroxide in methanol (2 mol/L) as per ISO standard 15885. FA composition was determined using a gas chromatograph (GC; Agilent 6890, www.agilent.com) equipped with an on-column injector and FID (19 (21) . The analysis was performed on an Agilent LC series 1100 equipped with a photodiode array detector (234 nm) using three ChromSpher Lipids columns in series (stainless steel, 250 × 4.6 mm, 5 µm particle size; Chrompack, Middleburg, The Netherlands). The solvent consisted of UV-grade hexane with 0.1% acetonitrile and 0.5% ethyl ether (flow rate 1 mL min −1 ), prepared fresh daily. Injection volumes were 10 µL, representing <250 µg lipid. The identification of CLA isomers was based on co-injection with commercial reference material and synthesized CLA. The methyl esters of c9,t11 (98%), t10,c12 (98%), and c9,t11 18:2 (75-78%) were obtained from Matreya Inc. (Pleasant Gap, PA). Other CLA isomers were synthesized by isomerization of the commercially available reference (technical grade) with I 2 (22) . The results were expressed as absolute values in mg per 100 g fat. Fourteen different CLA isomers were separated by this HPLC method (Fig. 1) .
Statistical analysis. A power calculation was performed based on an expected difference in CLA human milk content of 30% between the two phases, Alpine butter (AB) and margarine (M). The power was 80% for n = 8/group (α = 0.5).
Data were entered into Excel, analyzed in Systat for Windows, version 10.2 (www.uic.edu/depts/accc/software), and expressed as means ± SD. The Kolmogorov-Smirnov test was used for normality. Mean values were compared using the unpaired two-tailed t-test for cross-over design and a P value of <0.05. "Effect" refers to the differences between the two phases AB vs. M of group-pooled data, and "period" to the period effect, i.e., the differences between the two phases AB and M of group 1 vs. group 2.
RESULTS

Subjects.
Three women withdrew because of lactation failure and one developed diarrhea in response to Alpine butter, leaving eight subjects per group. The groups did not differ statistically in age (27.8 ± 3.5 vs. 29.5 ± 5.6 yr, respectively), parity, gravidity, gestational age at delivery, or body mass index (BMI) during the study (Table 2) .
Two group 2 women were excluded from the statistical analysis of the CLA isomers because of technical problems in the isomer analysis.
Study product intake and dietary diaries ( Table 3 ). The mean daily intake of margarine was 29.75 g (group 1) and 30.25 g (group 2) and that of Alpine butter 22.0 g (group 1) and 23.75 g (group 2). Study product intake was thus below the requested level (margarine: up to 40.0 g; Alpine butter: up to 30.0 g). The higher intake of margarine than butter (P = 0.003) resulted in an equal daily fat intake in both groups (P = 0.25 differences between M and AB [effect] and differences between the groups [period]). Fat intake was calculated from 60 g fat/100 g (margarine) and 85.8 g fat/100 g (Alpine butter) as specified in the Subjects, Materials, and Methods section.
Dietary nonsupplement CLA intake, calculated from the daily dietary records, also did not differ statistically (P = 0.52) between phases or groups. Extremely small or zero amounts of ruminant meat (beef) were recorded in both groups, as requested (data not shown).
Human milk. (i) Fat content.
In neither group did fat content of human milk differ significantly between margarine and butter phases (group 1: 3.3 ± 0.6 vs. 3.4 ± 1.6 g/100 mL milk; group 2: 2.9 ± 1.3 vs. 3.4 ± 1.1 g/100 mL milk) corresponding to a mean fat yield (g) per breast of 1.94 in the margarine and 1.90 in the butter phase (NS).
(ii) FA. The sum of saturated FA increased by 2.057 g/100 g fat during the pooled butter phases (P = 0.03), 18:1 trans FA by 0.428 g/100 g fat (P = 0.001), and trans FA with CLA by 0.178 g/100 g fat (P = 0.005) (all without period effects). There were significant pooled-group decreases in the butter phases in the sum of PUFA (3.502 g/100 g fat), 18:2 (3.252 g/100 g fat), n-6 FA (3.571 g/100 g fat) (all P = 0.001), and the sum of unsaturated FA (3.389 g/100 g fat; P = 0.02) ( Table  4 ). The ratio of n-6/n-3 FA was lower in the butter than in the margarine phases (mean: 13.7 vs. 17.9, P < 0.01), but the dif- ference was only minimal if we consider a ratio of 1 vs. 50 in the corresponding study products (see Table 1 ). The butter phases showed highly significant pooled-group differences (g/100 g fat; all P < 0.001) vs. margarine in the following individual FA (Table 4) : increases in C 15 (0.116 g), C 16 (1.507 g), C 17 (0.072 g), C 18 (0.960 g), and t9,c12 + t11,c15 18:2 (0.043 g); decreases in c9,c12 18:2 (3.632 g), c,c20:2n-6 (0.056 g), and 20:3n-6 (0.062 g) FA.
CLA isomers. (i) At baseline.
The overall baseline concentration (D1, after normal nonstandardized diet, n = 14) showed a predominance of the c9,t11 (277 ± 195 mg/100 g fat, range 77-800), t9,t11 (13 ± 7 mg/100 g fat, range 4-31), and t11,c13 (12 ± 10 mg/100 g fat, range 2-37) 18:2 isomers, and a total CLA concentration of 352 ± 229 mg/100 g fat (range 103-956).
(ii) During the study. Analysis of the mean pooled study day values (D5 + D10 and D15 + D20, respectively), showed significant increases in t12,t14, t11,t13, t6,t8, c11,t13, t11,c13, c9,t11, and t8,c10 18:2 as well as in the sum of CLA isomers during Alpine butter intake of both groups (Table 4 ). There were no significant period effects. Pooled-group increases of the individual isomers, expressed per 100 g fat, are shown in Figure 2 . The sum of CLA isomers increased by 129.4 mg (45.0%, P = 0.005) and the ratio of t11,c13 and t7,c9 18:2 isomers by 70.8% (P < 0.0001).
DISCUSSION
This study demonstrated that 10-d supplementation with Alpine butter, a natural CLA-rich product, affects the FA and CLA isomer content of human milk.
Butter significantly increased the concentrations of saturated FA. At study start (after a normal nonstandardized diet), 18 c9,t11 18:2 and total CLA concentrations in human milk were 277 ± 195 (range 7-800) and 352 ± 229 (range 103-956) mg/100 g fat, respectively. The isomers showing the highest increases in milk were t11,c13 (100.5%), t6,t8 (67.3 %), t12,t14 (61.3%), c9,t11 (49.7%), c11,t13 (39.6%), t11,t13 (34.0%), and t8,c10 (28.2%) (all P < 0.05).
Ethical limitations in standardization and compliance, which was not 100% in our study (Table 3) , make human data inevitably more variable than their dairy counterparts. The women were allowed to consume their total supplement per 24 h in as many portions as they wished, and we could not control for the well-known differences in absorption relating to the amount of fat per portion (23) . However, our study has certain advantages compared with others with human milk (9,10). The cross-over design excluded interindividual differences and differences due to lactation duration; all subjects consumed the same supplements with defined fat content and FA composition; milk sampling was standardized (volume, time of day) to minimize the effect of differential fat absorption (23) and milk volume (24) ; dietary intake of other dairy and beef products was recorded daily throughout the study; BMI was calculated throughout; milk analysis was longitudinal, with two time points per period. Since no significant differences were found in compliance, BMI, dietary (nonsupplement) CLA intake, or total milk fat content between periods or groups, these factors can be excluded as accounting for the differential milk content of FA or CLA isomers in response to butter supplementation.
Our basal value in human milk for the predominant isomer (c9,t11 18:2) (0.25 g/100 g fat) is similar to those reported by (12) in lactating American mothers during the lowdairy periods (10, 25, 26) or in baseline (12) . However, McGuire et al. (27) and Innis and King (28) recorded higher basal values (0.4 g/100 g fat) in American mothers, matching those in German mothers (0.39 and 0.40 g/100 g fat) (29) .
The increase in the predominant c9,t11 isomer in our study by 109.8 mg/100 g fat (49.7%) approximates that reported by Park et al. (10) (64.6%) from the low to the high CLA dairy period of their study and is higher than that reported by Ritzenthaler et al. (12) (29.0%) from baseline to 4 wk of consumption of high-CLA cheese. Unlike us, earlier investigators into human milk CLA content could identify, in addition to the predominant c9,t11 18:2 isomer, only t9,t11 (29) , t10,c12 (12, 27, 29) , t7,c9 (30) , and t9,t11/t10,t12 18:2 (12). In milk from German women, c9,t11 18:2 accounted for no more than 0.39%, t9,t11 18:2 at most 0.04%, and t10,c12 18:2 at most 0.08% of total FA (29) . For Yurawecz et al. (30) , the t7,c9 18:2 isomer accounted for 5.5-9.9% of total CLA. In our study, the c9,t11, t9,t11, t7,c9, and t10,c12 isomers accounted for 0.380, 0.019, 0.018, and 0.002% of total FA and for 79, 3.9, 3.6, and 0.3% of total CLA; these values are consistent with those indicated above.
The distribution of other FA in milk during the study periods reflects some but not all of the differences between supplements ( Table 1 ). The 18:1 trans FA other than trans10-11, which occur in low concentrations in both study products, also show low concentrations in human milk during both phases. This aspect could be of interest because in recent years attention has been given to the potential impairment of EFA metabolism to their long-chain metabolites by the trans-isomers in humans (31) . It is therefore unlikely that the small amounts found in human milk in our study have any important negative effect on the newborn. The higher amounts of C 15 , C 16 , C 17 , and C 18 acids and the trans unsaturated octadecadienoic acids (t9,c12 + t11,c15 18:2) are likely to have resulted from their higher content in Alpine butter. C 15 sized by ruminant flora but not in humans owing to the uneven number of carbon atoms (32) . They thus act as markers of a dairy fat diet (33, 34) . The highly significant decrease (3.63 g/100 g milk fat = 26.3%) in octadecadienoic acid (c9,c12 18:2) on butter vs. margarine is also probably due to its much lower content in butter than in margarine (1.53 g vs. 46.70 g/100 g fat). The n-6 FA that occur at high concentrations in margarine have an extremely low transfer into human milk.
Mothers can rapidly and easy modulate the fat composition of their milk by consuming Alpine butter (or related natural dairy products). This could have positive implications for the newborn. Several studies, most of them in animals, have indicated the potential impact of CLA-rich milk on the development of the newborn. One point could be the potential effect on body weight. In rats, the c9,t11 18:2 isomer increases body weight (14, 35) , whereas the t10,c12 18:2 isomer decreases it in both mice (35, 36) and humans [loss of body fat in diabetics (37) ]. Another point could be the protection of CLA-rich milk against development of atopy. In rats and mice, oral supplementation with 100 mg/kg CLA (isomer profile unknown) reduces allergic anaphylaxis (by decreasing blood pressure), vasodilatation, and scratching behavior in response to egg-white lysozyme (38) . However, further studies in humans are necessary to confirm these effects and to show whether human milk with a special pattern of FA and CLA could be a functional food for newborns. 
